<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910520-0118</DOCNO><DOCID>910520-0118.</DOCID><HL>   Who's News:   Eli Lilly andamp; Co. Realigns   Management as Lange   Nears Retirement Date</HL><DATE>05/20/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B3</SO><CO>   LLY WNEWS</CO><MS>CONSUMER NON-CYCLICAL (NCY)</MS><IN>DRUG MANUFACTURERS (DRG)</IN><NS>PERSONNEL ANNOUNCEMENTS, PROMOTIONS, APPOINTMENTS (PER)</NS><RE>INDIANA (IND)</RE><LP>   INDIANAPOLIS -- Eli Lilly andamp; Co. announced severalmanagement changes related to the planned June 30 retirementof E. Walter Lange, 59-year-old group vice president ofmarketing, planning and development for the company'sflagship pharmaceutical division.   Sidney A. Taurel, 42 years old and currently president ofthe company's Eli Lilly International Corp. unit, was namedexecutive vice president of the parent's pharmaceuticaldivision, responsible for worldwide marketing, planning anddevelopment.</LP><TEXT>   Succeeding Mr. Taurel as the international unit'spresident is Ronald A. Matricaria, 49, currently president ofthe parent's Medical Devices andamp; Diagnostics unit.   Both Mr. Taurel and Mr. Matricaria will report to EugeneL. Step, who is a Lilly executive vice president andpresident of the pharmaceutical division.   Mr. Matricaria's post as president of the devices anddiagnostics operation will be assumed by Ronald W. Dollens,44, who is currently the division's vice president, and headof the division's Advanced Cardiovascular Systems unit.</TEXT></DOC>